REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmas D.O.O. Beograd (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmas D.O.O. Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharmas D.O.O. Beograd is an enterprise in Serbia, with the main office in Belgrade. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on June 11, 2001. There are currently 52 (2020) people employed by Pharmas D.O.O. Beograd. The latest financial highlights indicate a net sales revenue increase of 9.37% in 2022. Its’ total assets recorded a negative growth of 4.99%. The enterprise’s net profit margin decreased by 6.46% in 2022.

Headquarters
Viline Vode BB
Belgrade; Belgrade; Postal Code: 11000

Contact Details: Purchase the Pharmas D.O.O. Beograd report to view the information.

Website: http://www.himedic.co.rs

Basic Information
Total Employees:
Purchase the Pharmas D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Pharmas D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Pharmas D.O.O. Beograd report to view the information.
Incorporation Date:
June 11, 2001
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmas D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
9.37%
Total operating revenue
11.57%
Operating profit (EBIT)
-34.24%
EBITDA
-28.94%
Net Profit (Loss) for the Period
-25.86%
Total assets
-4.99%
Total equity
33.55%
Operating Profit Margin (ROS)
-11.17%
Net Profit Margin
-6.46%
Return on Equity (ROE)
-20.92%
Debt to Equity Ratio
-73.46%
Quick Ratio
-0.06%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?